Details for New Drug Application (NDA): 020538
✉ Email this page to a colleague
The generic ingredient in VIVELLE-DOT is estradiol. There are seventy-five drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the estradiol profile page.
Summary for 020538
Tradename: | VIVELLE-DOT |
Applicant: | Sandoz |
Ingredient: | estradiol |
Patents: | 0 |
Pharmacology for NDA: 020538
Mechanism of Action | Estrogen Receptor Agonists |
Medical Subject Heading (MeSH) Categories for 020538
Suppliers and Packaging for NDA: 020538
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
VIVELLE-DOT | estradiol | SYSTEM;TRANSDERMAL | 020538 | NDA | Novartis Pharmaceuticals Corporation | 0078-0343 | 0078-0343-42 | 8 POUCH in 1 BOX (0078-0343-42) / 1 PATCH in 1 POUCH (0078-0343-62) / 3.5 d in 1 PATCH |
VIVELLE-DOT | estradiol | SYSTEM;TRANSDERMAL | 020538 | NDA | Novartis Pharmaceuticals Corporation | 0078-0344 | 0078-0344-42 | 8 POUCH in 1 BOX (0078-0344-42) / 1 PATCH in 1 POUCH (0078-0344-62) / 3.5 d in 1 PATCH |
Profile for product number 005
Active Rx/OTC/Discontinued: | RX | Dosage: | SYSTEM;TRANSDERMAL | Strength | 0.0375MG/24HR | ||||
Approval Date: | Jan 8, 1999 | TE: | AB1 | RLD: | Yes |
Profile for product number 006
Active Rx/OTC/Discontinued: | RX | Dosage: | SYSTEM;TRANSDERMAL | Strength | 0.05MG/24HR | ||||
Approval Date: | Jan 8, 1999 | TE: | AB1 | RLD: | Yes |
Profile for product number 007
Active Rx/OTC/Discontinued: | RX | Dosage: | SYSTEM;TRANSDERMAL | Strength | 0.075MG/24HR | ||||
Approval Date: | Jan 8, 1999 | TE: | AB1 | RLD: | Yes |
Expired US Patents for NDA 020538
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sandoz | VIVELLE-DOT | estradiol | SYSTEM;TRANSDERMAL | 020538-007 | Jan 8, 1999 | ⤷ Sign Up | ⤷ Sign Up |
Sandoz | VIVELLE-DOT | estradiol | SYSTEM;TRANSDERMAL | 020538-007 | Jan 8, 1999 | ⤷ Sign Up | ⤷ Sign Up |
Sandoz | VIVELLE-DOT | estradiol | SYSTEM;TRANSDERMAL | 020538-006 | Jan 8, 1999 | ⤷ Sign Up | ⤷ Sign Up |
Sandoz | VIVELLE-DOT | estradiol | SYSTEM;TRANSDERMAL | 020538-009 | May 3, 2002 | ⤷ Sign Up | ⤷ Sign Up |
Sandoz | VIVELLE-DOT | estradiol | SYSTEM;TRANSDERMAL | 020538-008 | Jan 8, 1999 | ⤷ Sign Up | ⤷ Sign Up |
Sandoz | VIVELLE-DOT | estradiol | SYSTEM;TRANSDERMAL | 020538-009 | May 3, 2002 | ⤷ Sign Up | ⤷ Sign Up |
Sandoz | VIVELLE-DOT | estradiol | SYSTEM;TRANSDERMAL | 020538-005 | Jan 8, 1999 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription